That report, along with separate findings in Scotland, highlight the significant impact the inoculations are already having in countries with the most advanced vaccination campaigns. The Pfizer shot also appeared to stop the vast majority of recipients in Israel from becoming infected, according to reports.
Hospitalizations and deaths from Covid-19 are reduced by more than 75% in those who have received a dose of the Pfizer-BioNTech vaccine, the preliminary findings by Public Health England show. The vaccine also shows high levels of protection against the variant, called B.1.1.7, first identified in southeast England, officials said. The results should further ease concerns about the UK’s decision to delay second doses of the two-shot Pfizer and AstraZeneca Plc vaccines to speed up protection for more people.
The data in Scotland showed vaccination reduced the risk of hospitalization by over 80%. The shot developed by AstraZeneca and Oxford cut hospital admissions by 94% by the fourth week after a single dose, with the one from Pfizer leading to an 85% reduction, according to the results in Scotland. So far, some 17.5 million people have had a first dose, about a third of all adults in the UK.